SES Solar Inc
SES Solar Inc. develops and delivers products in the field of photovoltaic energy in Switzerland. The company offers a range of photovoltaic products, such as solar tiles that comprise standard panels primarily for urban or rural areas, and flat or sloped roofs; and custom/architecturally integrated panels made of glass/glass tedlar, which are used for glazing, light admitting apertures in indust… Read more
SES Solar Inc (SESI) - Net Assets
Latest net assets as of September 2010: $3.04 Million USD
Based on the latest financial reports, SES Solar Inc (SESI) has net assets worth $3.04 Million USD as of September 2010.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.74 Million) and total liabilities ($16.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.04 Million |
| % of Total Assets | 15.41% |
| Annual Growth Rate | N/A |
| 5-Year Change | -103.91% |
| 10-Year Change | N/A |
| Growth Volatility | 186.37 |
SES Solar Inc - Net Assets Trend (2002–2019)
This chart illustrates how SES Solar Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SES Solar Inc (2002–2019)
The table below shows the annual net assets of SES Solar Inc from 2002 to 2019.
| Year | Net Assets | Change |
|---|---|---|
| 2019-12-31 | $-220.85K | -111.33% |
| 2009-12-31 | $1.95 Million | -40.46% |
| 2008-12-31 | $3.28 Million | -17.23% |
| 2007-12-31 | $3.96 Million | -29.96% |
| 2006-12-31 | $5.65 Million | +7904.57% |
| 2005-12-31 | $-72.39K | -120.82% |
| 2004-12-31 | $-32.78K | -508.47% |
| 2003-12-31 | $8.03K | +232.57% |
| 2002-12-31 | $-6.05K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SES Solar Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 828987400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2019)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $73.08K | % |
| Other Comprehensive Income | $-73.08K | % |
| Other Components | $8.13 Million | % |
| Total Equity | $-220.85K | 100.00% |
SES Solar Inc Competitors by Market Cap
The table below lists competitors of SES Solar Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MTEMQ
NASDAQ:MTEMQ
|
$0.97 |
|
StarTronix International Inc
OTCGREY:STNX
|
$0.97 |
|
Kiley Group Inc.
PINK:KGRI
|
$0.97 |
|
GainClients Inc
PINK:GCLT
|
$0.97 |
|
Nexis International Industries Inc
PINK:NXSI
|
$0.97 |
|
Media Way Corp
PINK:MDAW
|
$0.97 |
|
Protek Capital Inc.
PINK:PRPM
|
$0.97 |
|
Genex Pharmaceutical Inc
PINK:GENX
|
$0.97 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SES Solar Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2009 to 2019, total equity changed from 1,950,020 to -220,854, a change of -2,170,874 (-111.3%).
- Net loss of 15,854 reduced equity.
- Other comprehensive income increased equity by 616,537.
- Other factors decreased equity by 2,771,557.
Equity Change Factors (2009 to 2019)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.85K | -7.18% |
| Other Comprehensive Income | $616.54K | +279.16% |
| Other Changes | $-2.77 Million | -1254.93% |
| Total Change | $- | -111.33% |
Book Value vs Market Value Analysis
This analysis compares SES Solar Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $0.00 | $0.00 | x |
| 2006-12-31 | $0.19 | $0.00 | x |
| 2007-12-31 | $0.07 | $0.00 | x |
| 2008-12-31 | $0.04 | $0.00 | x |
| 2009-12-31 | $0.03 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SES Solar Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-166.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $-42.54K |
| 2003 | -1361.20% | 0.00% | 0.00x | 4.02x | $-110.05K |
| 2004 | 0.00% | -18310.95% | 1.49x | 0.00x | $-83.70K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-52.37K |
| 2006 | -21.94% | -958.81% | 0.02x | 1.29x | $-1.80 Million |
| 2007 | -38.51% | -113.33% | 0.09x | 3.62x | $-1.92 Million |
| 2008 | -14.49% | -1419.84% | 0.00x | 5.18x | $-801.99K |
| 2009 | -62.32% | -90.94% | 0.06x | 12.00x | $-1.41 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $6.23K |
Industry Comparison
This section compares SES Solar Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SES Solar Inc (SESI) | $3.04 Million | 0.00% | 5.49x | $0.97 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |